EOLS
Evolus IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$443.20M
P/E Ratio
—
EPS
$-0.66
Beta
1.33
52W High
$10.20
52W Low
$3.86
50-Day MA
$5.73
200-Day MA
$5.92
Dividend Yield
—
Profit Margin
-14.40%
Forward P/E
61.35
PEG Ratio
—
About Evolus Inc
Evolus, Inc., a high-performance beauty company, provides aesthetic medical products for physicians and their patients in the United States. The company is headquartered in Newport Beach, California.
Fundamentals
| Revenue (TTM) | $301.79M |
| Gross Profit (TTM) | $199.35M |
| EBITDA | $-23.15M |
| Operating Margin | -9.38% |
| Return on Equity | -18730.00% |
| Return on Assets | -9.06% |
| Revenue/Share (TTM) | $4.65 |
| Book Value | $-0.44 |
| Price-to-Book | 53.71 |
| Price-to-Sales (TTM) | 1.47 |
| EV/Revenue | 1.85 |
| EV/EBITDA | -21.50 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 6.70% |
| Shares Outstanding | $65.86M |
| Float | $50.04M |
| % Insiders | 14.68% |
| % Institutions | 70.04% |
Historical Volatility
HV 10-Day
62.49%
HV 20-Day
55.98%
HV 30-Day
62.08%
HV 60-Day
59.13%
HV Rank
69.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($14.67 target)
1
Strong Buy5
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026